Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
1.000
0.00 (0.03%)
Mar 14, 2025, 11:31 AM EDT - Market open
Inozyme Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
Cash & Equivalents | 21.08 | 34.59 | 32.92 | 23.32 | 28.04 | Upgrade
|
Short-Term Investments | 92.01 | 154 | 94.95 | 88.49 | 119.66 | Upgrade
|
Cash & Short-Term Investments | 113.09 | 188.59 | 127.87 | 111.8 | 147.7 | Upgrade
|
Cash Growth | -40.04% | 47.49% | 14.37% | -24.30% | 213.37% | Upgrade
|
Other Receivables | 0.47 | 0.39 | 0.12 | 0.06 | 0.16 | Upgrade
|
Receivables | 0.47 | 0.39 | 0.12 | 0.06 | 0.16 | Upgrade
|
Prepaid Expenses | 6.81 | 7.28 | 3.41 | 3.48 | 3.13 | Upgrade
|
Restricted Cash | 0.31 | - | - | - | - | Upgrade
|
Total Current Assets | 120.68 | 196.25 | 131.39 | 115.34 | 150.98 | Upgrade
|
Property, Plant & Equipment | 1.35 | 2.59 | 3.64 | 4.44 | 2.65 | Upgrade
|
Long-Term Investments | - | - | - | - | 12.2 | Upgrade
|
Other Long-Term Assets | 1.16 | 2.01 | 4.16 | 3.76 | 3.54 | Upgrade
|
Total Assets | 123.18 | 200.85 | 139.2 | 123.54 | 169.36 | Upgrade
|
Accounts Payable | 2.53 | 1.17 | 2.54 | 2.39 | 3.07 | Upgrade
|
Accrued Expenses | 15.95 | 12.61 | 11.36 | 8.51 | 6.63 | Upgrade
|
Current Portion of Long-Term Debt | 14.5 | - | - | - | - | Upgrade
|
Current Portion of Leases | 0.91 | 0.91 | 0.82 | 0.73 | - | Upgrade
|
Other Current Liabilities | - | - | - | - | 0.28 | Upgrade
|
Total Current Liabilities | 33.9 | 14.69 | 14.72 | 11.63 | 9.97 | Upgrade
|
Long-Term Debt | 31.46 | 44.77 | 4.14 | - | - | Upgrade
|
Long-Term Leases | - | 0.91 | 1.82 | 2.64 | - | Upgrade
|
Other Long-Term Liabilities | - | - | 0.12 | - | 1.29 | Upgrade
|
Total Liabilities | 65.36 | 60.37 | 20.8 | 14.27 | 11.26 | Upgrade
|
Common Stock | 0.01 | 0.01 | 0 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 445.71 | 426.36 | 333.36 | 256.95 | 249.18 | Upgrade
|
Retained Earnings | -387.95 | -285.93 | -214.76 | -147.7 | -91.08 | Upgrade
|
Comprehensive Income & Other | 0.07 | 0.04 | -0.21 | 0.02 | 0 | Upgrade
|
Total Common Equity | 57.83 | 140.48 | 118.39 | 109.27 | 158.1 | Upgrade
|
Shareholders' Equity | 57.83 | 140.48 | 118.39 | 109.27 | 158.1 | Upgrade
|
Total Liabilities & Equity | 123.18 | 200.85 | 139.2 | 123.54 | 169.36 | Upgrade
|
Total Debt | 46.87 | 46.59 | 6.78 | 3.37 | - | Upgrade
|
Net Cash (Debt) | 66.21 | 142 | 121.09 | 108.43 | 147.7 | Upgrade
|
Net Cash Growth | -53.37% | 17.27% | 11.67% | -26.59% | 213.37% | Upgrade
|
Net Cash Per Share | 1.05 | 2.74 | 3.21 | 4.60 | 13.38 | Upgrade
|
Filing Date Shares Outstanding | 64.24 | 61.77 | 43.72 | 23.67 | 23.46 | Upgrade
|
Total Common Shares Outstanding | 64.24 | 61.77 | 40.39 | 23.67 | 23.38 | Upgrade
|
Working Capital | 86.78 | 181.56 | 116.68 | 103.71 | 141.01 | Upgrade
|
Book Value Per Share | 0.90 | 2.27 | 2.93 | 4.62 | 6.76 | Upgrade
|
Tangible Book Value | 57.83 | 140.48 | 118.39 | 109.27 | 158.1 | Upgrade
|
Tangible Book Value Per Share | 0.90 | 2.27 | 2.93 | 4.62 | 6.76 | Upgrade
|
Machinery | 1.77 | 1.72 | 1.62 | 1.29 | 0.88 | Upgrade
|
Leasehold Improvements | 2.17 | 2.16 | 2.13 | 2.1 | 2.1 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.